News Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2026-05-11 EDT			5-day change	1st Jan Change
300.00 ^DKK	+3.34%		+7.91%	-7.76%

05-11	Hims & Hers misses revenue estimates as strategy shift hits sales	RE
05-11	Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarity	RE

All News

Mentions Relevance

05-11	Hims & Hers misses revenue estimates as strategy shift hits sales	RE
05-11	Cellular Intelligence Announces Agreement with Novo Nordisk for Global Rights to Clinical-Stage Parkinson's Cell Therapy Program	CI
05-11	Novo Nordisk to Sell Parkinson's Cell Therapy to Startup Cellular Intelligence	DJ
05-11	Cellular Intelligence Acquires Global Rights to Parkinson's Cell Therapy Program from Novo Nordisk	MT
05-11	Cellular intelligence enters agreement with Novo Nordisk to advance clinical-stage Parkinson's cell therapy	RE
05-11	Novo Nordisk hands over Parkinson's project to AI startup Cellular Intelligence	FW
05-11	Novo Nordisk Agrees Divestment of Parkinson's Disease Cell Therapy Program to Cellular Intelligence	MT
05-11	Zuckerberg backed-Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy	RE
05-11	Novo Nordisk Agrees Divestment of Parkinson's Disease Cell Therapy Program to Cellular Intelligence	MT
05-11	Cellular Intelligence enters into agreement with Novo Nordisk to acquire STEM-PD	RE
05-11	Citi raises Novo Nordisk price target following strong Wegovy pill launch	FW
05-11	SB1: Market underestimates Novo Nordisk potential - raises price target	FW
05-11	SB1 Markets raises Novo Nordisk price target to DKK 350 (280), reiterates Buy	FW
05-11	Citigroup raises Novo Nordisk price target to DKK 290 (275), reiterates Neutral rating	FW
05-08	Novo Nordisk sales surge in India following price cuts	FW
05-08	NOVO NORDISK : Deutsche Bank gives a Neutral rating	ZD
05-08	Novo Nordisk's Diabetes, Weight-Loss Drug Sales in India Rise After Price Cuts	MT
05-08	NOVO NORDISK : Gets a Neutral rating from JP Morgan	ZD
05-08	NOVO NORDISK : UBS sticks Neutral	ZD
05-08	Novo Nordisk Sees 40% Jump in India Sales of Weight-Loss Drug After Price Cuts	MT
05-08	NOVO NORDISK : Barclays sticks Neutral	ZD
05-08	DZ Bank trims Novo Nordisk price target to DKK 299 (307), reiterates Hold - BN	FW
05-08	Nykredit raises Novo Nordisk price target to DKK 350 (300), reiterates Buy - BN	FW
05-07	Novo Nordisk A/S : (tax report 2025 novo nordisk)	PU
05-07	NOVO NORDISK : DZ Bank gives a Neutral rating	ZD